Home » Mylan Begins Marketing First Generic Version of Desoxyn
Mylan Begins Marketing First Generic Version of Desoxyn
Mylan Inc. Monday announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market Methamphetamine Hydrochloride Tablets USP, 5 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.
TheStreet
TheStreet
Upcoming Events
-
07May
-
14May
-
30May